Research programme: BK potassium channel modulators - NeuroSearch/TopoTarget
Alternative Names: NSD-551Latest Information Update: 27 Aug 2007
At a glance
- Originator NeuroSearch
- Developer NeuroSearch; TopoTarget
- Class
- Mechanism of Action Potassium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Brain cancer
Most Recent Events
- 22 Aug 2007 Discontinued - Preclinical for Brain cancer in Denmark (unspecified route)
- 14 May 2007 Preclinical development is ongoing
- 30 Aug 2005 NeuroSearch and TopoTarget have entered into an agreement to co-develop and co-promote NSD 551